Carter's Aromatherapy Designs (C.A.D.) Cannabis Brand Logo

Carter's Aromatherapy Designs (C.A.D.)

Data Snapshot: Aug 04, 2026
$50K+

Jul-2026

Sales

Neutral

Trend

6-Month

28

Product Count

SKUs

$39.33

Avg Price

-20.9%

YoY Sales Change

-4.3%

YoY Price Change

Carter's Aromatherapy Designs (C.A.D.) is a revered brand in the cannabis industry, specializing in the manufacture of products enriched with CBD such as creams, capsules, and tinctures. The brand distinguishes with quality products, and recipes infused with MCT oil, a form of coconut oil, which increases efficiency of CBD intake. C.A.D. gains further respect through community involvement and philanthropy, notably partnering with California's Perfect Union to raise money during Breast Cancer Awareness Month.
Carter's Aromatherapy Designs (C.A.D.)

Where to Buy

Carter's Aromatherapy Designs (C.A.D.) is stocked at 33 licensed dispensaries across California, with the deepest coverage in Sacramento, Modesto, Stockton, Marysville, and Oakland. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/3316.json?v=20260804
Carter's Aromatherapy Designs (C.A.D.) Sales

Market Insights Snapshot

Carter's Aromatherapy Designs (C.A.D.) Historical Sales by Category

In July 2026, Carter's Aromatherapy Designs (C.A.D.) shifted toward a near two-way split between Topical at 52.23% share and Tincture & Sublingual at 47.35% share, with Topical down 25.42% year over year and 23.61% month over month while Tincture & Sublingual declined 15.03% year over year but rose 25.19% month over month. Capsules contracted to 0.42% share with a 28.73% year-over-year decline and a 67.28% month-over-month drop, and average price across the brand fell 4.34% year over year even as Topical averaged $49.92 versus $32.20 in Tincture & Sublingual; the implication is that mix is tilting away from higher-priced Topical toward faster-rebounding Tincture & Sublingual, complicating revenue recovery amid a brand-level sales decline of 20.85% year over year.

With a Topical rank of 6 in California anchoring visibility, the 23.61% month-over-month drop in Topical alongside a 25.19% month-over-month gain in Tincture & Sublingual signals a pivot from a premium-priced leader SKU set to mid-priced formats that carry lower average transaction value. Given a 28.83% two-year sales decline and Topical’s 52.23% share still outweighing Tincture & Sublingual’s 47.35%, the pattern implies near-term volume stabilization may come from Tincture & Sublingual momentum, but overall revenue efficiency will depend on managing the price gap as mix shifts away from the category where the brand holds its current Topical rank position.

Jul-2026 Rank
Tincture & Sublingual
Topical
16
6
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Topical
52.2%
$49.92
-25.4%
-23.6%
Tincture & Sublingual
47.4%
$32.20
-15.0%
+25.2%
Capsules
0.4%
$16.26
-28.7%
-67.3%
Carter's Aromatherapy Designs (C.A.D.)

Competitive Landscape

Carter's Aromatherapy Designs (C.A.D.) sits at rank #6 in CA Topical in July 2026, down 2 positions from #4 year over year and 1 position from #5 in April 2026, while its best showing of #4 came in January 2026; meanwhile, Papa & Barkley held #1 with a 6.1% YoY sales decline and Liquid Flower rose to #4 from #6 with a 60.5% YoY increase, indicating Carter's Aromatherapy Designs (C.A.D.) is ceding relative position to faster-rising peers despite stability at the category’s top. This pattern—rank slippage of 2 places YoY to #6 alongside competitors like Buddies at #3 with 50.3% YoY growth and Sweet ReLeaf (CA) steady at #5 with a 0.1% YoY sales dip—implies Carter's Aromatherapy Designs (C.A.D.) must outpace mid-pack growers to avoid further share erosion as leadership remains sticky.

Carter's Aromatherapy Designs (C.A.D.) market ranking for CA Topical

Carter's Aromatherapy Designs (C.A.D.)

Notable Products

CBD/THC 1:1 Tincture (300mg CBD, 300mg THC, 1oz) posted the standout surge at +98% MoM to rank 5, while Tranquility Tincture (1000mg THC, 2mg CBD, 29ml) fell 35% MoM yet held rank 1, indicating share is rotating within the tincture lineup rather than exiting the brand. CBD/THC Uplift Tincture (330mg CBD, 14.5mg THC, 29ml) climbed 94% MoM to rank 4 as CBD/THC Everyday Tincture (200mg CBD, 4.4mg THC, 1oz) slid 25% MoM to rank 9, and three other tinctures rose between +86% and +2% while the top topical declined 38% at rank 2. Seven of the top ten are Tincture & Sublingual SKUs, and the concentration alongside simultaneous +98% and +86% uplifts points to a tilt toward balanced and functional tinctures over topicals. The pattern implies Carter's Aromatherapy Designs (C.A.D.) is consolidating around higher-velocity tinctures, reallocating demand away from creams and validating a tincture-led pricing and assortment strategy even as the $13,822 Rasta Pain Cream contracts.

Product
Category
Mar-2026
Apr-2026
May-2026
Jun-2026
Jul-2026
MoM %
Tranquility Tincture (1000mg THC, 2mg CBD, 29ml)
Tincture & Sublingual
2
2
5
3
1
-0.4%
CBD/THC 2:1 Rasta Pain Cream (1000mg CBD, 500mg THC, 2oz)
Topical
1
1
1
1
2
-37.9%
CBD:THC 2:1 Mimosa Cream (215mg CBD, 130mg THC, 1.9oz)
Topical
3
3
4
2
3
+3.2%
CBD/THC Uplift Tincture (330mg CBD, 14.5mg THC, 29ml)
Tincture & Sublingual
6
7
3
6
4
+93.6%
CBD/THC 1:1 Tincture (300mg CBD, 300mg THC, 1oz)
Tincture & Sublingual
5
4
7
10
5
+98.2%
CBD/THC Elevation Tincture (1150mg CBD, 40mg THC)
Tincture & Sublingual
>10
5
9
8
6
+85.7%
CBD/THC 1:1 Tincture (200mg CBD, 220mg THC)
Tincture & Sublingual
>10
>10
>10
>10
7
CBN/THC 1:1 Nana's Nighttime CBN Tincture (220mg CBN, 220mg THC)
Tincture & Sublingual
7
8
>10
5
8
+2.0%
CBD/THC Everyday Tincture (200mg CBD, 4.4mg THC, 1oz)
Tincture & Sublingual
8
9
10
4
9
-25.0%
CBD/THC Relaxation Tincture (13.6mg CBD, 530mg THC)
Tincture & Sublingual
9
10
6
>10
10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market